Home › Stocks › VLON

VLON — VALLON PHARMACEUTICALS INC

Reported value held$94.14K
Funds holding (latest)11
Sector—

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

VLON (VALLON PHARMACEUTICALS INC) is tracked on HoldingsHub across five years of quarterly 13F filings. 11 funds have reported positions historically, with the sum of their latest reported stakes valued at $94.14K. No fund in our coverage reported a position in the latest filing period, which typically means the stock has fallen out of the tracked funds' portfolios rather than that it cannot be bought.

Major shareholders of VALLON PHARMACEUTICALS INC (VLON) include Renaissance Technologies, Two Sigma Investments, Geode Capital Management, ranked by reported 13F value among the 11 institutional holders on this page.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Institutional Ownership by Quarter

Quarter Funds holding Shares Value QoQ Net Change
Q1 2023 4 35.64K $12.89K -41.5%
Q4 2022 6 115.17K $30.17K +0.0%
Q3 2022 3 53.72K $15.00K -2.9%
Q2 2022 6 172.36K $109.00K -59.3%
Q1 2022 5 134.37K $253.00K -28.8%
Q4 2021 4 188.15K $1.12M -17.8%
Q3 2021 3 28.26K $205.00K —

Over the 7 quarters shown, institutional share counts increased 26% in aggregate (Q3 2021 → Q1 2023); the largest single-quarter swing was Q2 2022 (-59.3%).

Top Institutional Holders (Q1 2023) — 4 funds

FundSharesValuePortfolio WeightChange
Geode Capital Management 21.57K $7.80K 0.00% Hold
Citadel Advisors 11.10K $4.01K 0.00% New
UBS Group AG 2.92K $1.06K 0.00% Reduce
Wells Fargo & Co 58 $21 0.00% Add

↑ Back to the top of the holders list

Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders

Q4 2022 — 6 funds

FundSharesValuePortfolio WeightChange
Two Sigma Investments 62.84K $18.22K 0.00% New
Geode Capital Management 21.57K $6.00K 0.00% Hold
UBS Group AG 20.35K $5.90K 0.00% New
Morgan Stanley 90 $26 0.00% New
Wells Fargo & Co 57 $17 0.00% New
Millennium Management 10.27K $3 0.00% New

Q3 2022 — 3 funds

FundSharesValuePortfolio WeightChange
Geode Capital Management 21.57K $6.00K 0.00% Hold
Vanguard Group 22.15K $6.00K 0.00% Reduce
Fidelity Management & Research (FMR) 10.00K $3.00K 0.00% New

Q2 2022 — 6 funds

FundSharesValuePortfolio WeightChange
Renaissance Technologies 78.89K $50.00K 0.00% New
Two Sigma Investments 42.39K $27.00K 0.00% New
Vanguard Group 23.46K $15.00K 0.00% Reduce
Geode Capital Management 21.57K $13.00K 0.00% Hold
Citigroup Inc 6.00K $4.00K 0.00% Add
Morgan Stanley 50 $0 — Reduce

Q1 2022 — 5 funds

FundSharesValuePortfolio WeightChange
Vanguard Group 101.66K $191.00K 0.00% Reduce
Geode Capital Management 21.57K $40.00K 0.00% Add
UBS Group AG 8.79K $17.00K 0.00% Add
Morgan Stanley 2.00K $4.00K 0.00% Reduce
Citigroup Inc 340 $1.00K 0.00% New

Q4 2021 — 4 funds

FundSharesValuePortfolio WeightChange
Vanguard Group 164.92K $986.00K 0.00% New
Geode Capital Management 17.84K $106.00K 0.00% Reduce
UBS Group AG 2.76K $17.00K 0.00% Add
Morgan Stanley 2.63K $16.00K 0.00% Hold

New Positions (latest)

No fund opened a new position this quarter.

Fully Exited (vs previous quarter)

No tracked fund fully exited this quarter.

Fund Position History — shares by quarter (top 11 funds)

FundQ1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Geode Capital Management 21.57K 21.57K 21.57K 21.57K 21.57K 17.84K 24.13K
Citadel Advisors 11.10K — — — — — —
UBS Group AG 2.92K 20.35K — — 8.79K 2.76K 1.50K
Wells Fargo & Co 58 57 — — — — —
Renaissance Technologies — — — 78.89K — — —
Citigroup Inc — — — 6.00K 340 — —
Millennium Management — 10.27K — — — — —
Vanguard Group — — 22.15K 23.46K 101.66K 164.92K —
Fidelity Management & Research (FMR) — — 10.00K — — — —
Morgan Stanley — 90 — 50 2.00K 2.63K 2.63K
Two Sigma Investments — 62.84K — 42.39K — — —

Download holders (CSV)

FAQ

Which funds hold VLON?

11 funds have reported positions in VLON across five years of 13F filings; the sum of their latest reported stakes is $94.14K.

Who are the top institutional holders of VLON?

The largest 13F holders are Renaissance Technologies, Two Sigma Investments, Geode Capital Management, Vanguard Group, Citadel Advisors; the top 25 are ranked at the top of this page.

Who are the major shareholders of VALLON PHARMACEUTICALS INC?

The major shareholders of VALLON PHARMACEUTICALS INC (VLON) by reported 13F value are Renaissance Technologies, Two Sigma Investments, Geode Capital Management, Vanguard Group, Citadel Advisors, among 11 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Embed this stock on your site

Copy the snippet below to show a live "which legendary investors own VLON" list on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/stocks/VLON/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

Preview the embeddable widget →